Status:

RECRUITING

The HIgh-fidelity Hydraulic couPling Upper-arm Cuff Assessment of Limits, Safety, and Effectiveness (HIPULSE) Trial

Lead Sponsor:

Philips Clinical & Medical Affairs Global

Conditions:

Cardiac Surgery, Non-Cardiac ICU

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this study is to compare measurements of blood pressure (BP) and fluid responsiveness between the Philips AMC and invasive radial arterial line in surgical patients.

Detailed Description

Primary Objective: • To evaluate equivalence of BP measurements (Systolic Blood Pressure \[SBP\], Diastolic Blood Pressure \[DBP\], and Mean Arterial Pressure \[MAP\]) derived from the Philips AMC to...

Eligibility Criteria

Inclusion

  • Adults aged 18 years and older
  • Indication for NIBP cuff
  • Indication for a radial arterial line
  • Subject or legal authorized representative is able to understand and speak the local language (also Spanish for US sites) to provide voluntary written informed consent prior to study procedures
  • The following stratification criteria must be met across the study sites and hence targeted enrollment may be required:
  • Age of every patient 18+; at least 30% \> 65 years, 30% ≤ 65 years
  • At least 30% male, 30% female
  • Minimum number of subjects needed to test each size cuff (per ISO81060-2:2018/AMD2:2024, based on limb circumference range):
  • Adult Small (19-27 cm) = 165\*\[8/(2\*24)\] = 28
  • Adult (25-34 cm) = 165\*\[9/(2\*24)\] = 31
  • Adult Large Short (30-40 cm with severely conical arm) = 165\*\[10/(2\*24)\] = 35
  • Adult Large (32-43 cm) = 165\*\[11/(2\*24)\] = 38
  • At least 40% of the subjects within each cuff size shall have a limb circumference that lies within the upper half of the specified range of use of the cuff
  • At least 40% of the subjects within each cuff size shall have a limb circumference within the lower half of the specified range of use of the cuff
  • At least 10% SBP measurements ≤ 100 mmHg
  • At least 10% SBP measurements ≥ 160 mmHg
  • At least 10% DBP measurements ≤ 70 mmHg
  • At least 10% DBP measurements ≥ 85 mmHg

Exclusion

  • Emergency surgery
  • Surgeries in which both arms are tucked
  • Inability to place the Philips AMC appropriately due to subject anatomy or condition
  • Known pregnancy or lactating women (self-report)
  • Patients treated with an intra-aortic balloon pump
  • Aortic and mitral regurgitation (\> 2nd degree), if known
  • Measurements taken in the lateral position
  • Pressure of the arterial line system, when tested at 100 mmHg with the VeriCal device, exceeds the +/- 2 mmHg threshold
  • Currently participating in an investigational drug or another device study that clinically interferes with the study endpoints
  • Upper arm circumference \< 19 cm or \> 43 cm
  • BMI \> 45
  • If the average of 3 baseline NIBP lateral difference measurements for SBP is \> 15 mmHg or for DBP is \> 10 mmHg
  • At the PI's discretion, subject does not qualify to participate in the study for any reasons that are not mentioned above

Key Trial Info

Start Date :

October 2 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

February 1 2026

Estimated Enrollment :

205 Patients enrolled

Trial Details

Trial ID

NCT06895590

Start Date

October 2 2025

End Date

February 1 2026

Last Update

December 10 2025

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States, 02215

2

Duke University Health System

Durham, North Carolina, United States, 27710

3

Wake Forest Baptist Medical Center

Winston-Salem, North Carolina, United States, 27157

4

LMU Klinikum

München, Bavaria, Germany, 81377